BridgeBio Oncology Therapeutics, Inc 10-K for FY2025
BridgeBio Oncology Therapeutics, Inc. (BBOT)
10-K
2026-03-05
For: 2025-12-31
View Original
Added on
April 10, 2026
About this 10-K
BridgeBio Oncology Therapeutics, Inc filed this 10-K on March 5, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $134.04M
- compared with a net loss of $74.28M a year earlier
- Diluted EPS
- -$4.30
- compared with -$5,756.41 a year earlier